Comments on "Physical activity and risk of thyroid cancer: a systematic review and meta-analysis of prospective cohort studies" [0.03%]
关于“系统综述和前瞻性队列研究荟萃分析中体力活动与甲状腺癌风险的关系”的评论
Arun Kumar,Ankur Sharma,Saumya Das et al.
Arun Kumar et al.
Impact of immunohistochemistry-based molecular classification with conventional risk stratification on recurrence and survival outcomes in endometrial cancer [0.03%]
基于免疫组化分子分型与传统风险分层的子宫内膜癌复发和生存预测价值研究
Yoshimasa Kawarai,Akira Mitsuhashi,Shuhei Noda et al.
Yoshimasa Kawarai et al.
Background: The conventional histomorphology-based risk classification for endometrial cancer (EC) does not consider the molecular heterogeneity that influences prognosis and treatment response. The Proactive Molecular Ri...
Association of fat-free mass index and survival in patients with lung cancer: a multicenter cohort study [0.03%]
去脂体重指数与肺癌患者的生存率关联：一项多中心队列研究
Gege Zhang,Hongxia Xu,Chuying Zhang et al.
Gege Zhang et al.
Background: Fat-free mass index (FFMI) is a prognostic influence in cancer patients. However, for the prognosis of Chinese lung cancer (LC) patients, the threshold and impact of FFMI are not known. The aim of the present ...
Prognostic stratification of recurrent colorectal liver metastasis: impact of recurrence-free interval, tumor numbers, and size on repeat liver resection [0.03%]
肝转移复发的预后分层：无复发生存期、肿瘤数目及大小对再次肝脏切除术的影响
Hajime Kamiya,Shin Kobayashi,Masashi Kudo et al.
Hajime Kamiya et al.
Background: This study investigated the prognostic factors of recurrent colorectal liver metastasis (r-CRLM) and the indications for repeat liver resection (RLR). ...
Prognostic role of hand grip strength (HGS) on outcomes after gastrectomy for gastric cancer: a systematic review and meta-analysis [0.03%]
手握力(HGS)在胃癌根治术后预后中的作用：系统回顾和 Meta 分析
Hsiao-Ling Chang,Chih-Ying Chien,Tzu-Ping Chen
Hsiao-Ling Chang
Background: Gastric cancer (GC) is a prevalent malignancy with a substantial impact on public health. Muscle quality and function may serve as predictors of poor clinical outcomes in GC. The aim of this updated meta-analy...
Pooled safety analysis of pimitespib for the treatment of patients with advanced gastrointestinal stromal tumors [0.03%]
用于治疗晚期胃肠间质瘤患者匹美替哌的汇总安全性分析
Yukinori Kurokawa,Noboru Yamamoto,Yuko Hirano et al.
Yukinori Kurokawa et al.
Background: Pimitespib is a first-in-class heat shock protein 90 (HSP90) inhibitor, approved in Japan for the treatment of advanced gastrointestinal stromal tumors (GIST). This study aimed to characterize the incidence an...
Effect of Vonoprazan, potassium-competitive acid blocker, on Atezolizumab plus Bevacizumab efficacy in patients with hepatocellular carcinoma: a multicenter retrospective study [0.03%]
钾竞争性酸阻滞剂vonoprazan对肝细胞癌患者阿特朱单抗联合贝伐珠单抗疗效影响的多中心回顾性研究
Masaya Takahashi,Katsuyuki Takahashi,Sawako Uchida-Kobayashi et al.
Masaya Takahashi et al.
Background: Proton pump inhibitors (PPIs) have received considerable attention as inducers of gut dysbiosis through gastric acid suppression. PPI-induced gut dysbiosis is associated with a poor prognosis in patients with ...
Prognostic impact and site-specific efficacy of systemic therapies in locally advanced or metastatic urothelial carcinoma: in an era of expanding therapeutic options [0.03%]
系统治疗在局部晚期或转移性尿路上皮癌的预后价值和部位特异性疗效：在治疗选择不断扩大的时代
Shoma Yamamoto,Minoru Kato,Taisuke Matsue et al.
Shoma Yamamoto et al.
Objective: Combination therapy with enfortumab vedotin (EV) and pembrolizumab has shown superior overall survival (OS) compared to platinum-based chemotherapy in advanced urothelial carcinoma (UC). Given the expanding lan...
Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2024 for the clinical practice of hereditary colorectal cancer [0.03%]
日本大肠癌学会2024年遗传性结直肠癌临床实践指南
Kohji Tanakaya,Tatsuro Yamaguchi,Keiji Hirata et al.
Kohji Tanakaya et al.
Approximately 5% of all colorectal cancers have a strong genetic component and are classified as hereditary colorectal cancer (HCRC). Some of the unique features commonly seen in HCRC cases include early age of onset, synchronous/metachrono...
Tomoya Emori,Masahiro Itonaga,Reiko Ashida et al.
Tomoya Emori et al.
Sarcopenia, characterized by loss of skeletal muscle mass and function, is a highly prevalent yet often overlooked condition in patients with gastrointestinal (GI) cancers. Emerging evidence suggests that sarcopenia is a significant predict...